Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 43Other hematologic neoplasm 36Myeloid 13Classical hematology 5Dermatologic 4Sarcoma 3Plasma cell 3CNS 3Breast 3Tumor-Agnostic 2Genitourinary 2Thoracic 1Head & Neck 1

Conditions

Breast Neoplasms 3Meningeal Carcinomatosis 1Brain Neoplasms 1

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × merphos × Breast × Clear all
NCT00194779 2018-03-12

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

University of Washington

Phase 2 Completed
50 enrolled 13 charts
Breast

Breast Neoplasms

NCT00194792 2017-07-11

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

University of Washington

Phase 2 Terminated
28 enrolled 9 charts
Breast

Breast Neoplasms

NCT00992602 2017-07-07

Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer

University of Washington

Phase 2 Completed
3 enrolled 8 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡